Literature DB >> 8143714

Pulmonary gas exchange in acute respiratory failure.

R Rodriguez-Roisin1.   

Abstract

The principal function of the lung is to facilitate the exchange of the respiratory gases, oxygen (O2) and carbon dioxide (CO2). When the lung fails as a gas exchanger respiratory failure ensues. Clinically, it is generally accepted that an arterial oxygen tension (PaO2) of less than 60 mmHg or a PaCO2 of greater than 50 mmHg, or both, whilst breathing room air are values consistent with the concept of respiratory failure. This article will deal, firstly, with some basic aspects of the physiology of pulmonary gas exchange and more specifically on the measurement of ventilation-perfusion (VA/Q) relationships, the most influential factor determining hypoxaemia. The second part highlights the most important findings on pulmonary gas exchange in the adult respiratory distress syndrome (ARDS) and other common acute respiratory failure conditions, such as pneumonia, acute exacerbation of chronic obstructive pulmonary disease (COPD) and status asthmaticus, based on the data obtained by means of the multiple inert gas elimination approach, a technique which gives a detailed picture of VA/Q ratio distributions.

Entities:  

Mesh:

Year:  1994        PMID: 8143714

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  5 in total

1.  Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.

Authors:  Abdullah F Al Harthi; Ohoud Aljuhani; Ghazwa B Korayem; Ali F Altebainawi; Raghdah S Alenezi; Shmeylan Al Harbi; Jawaher Gramish; Raed Kensara; Awattif Hafidh; Huda Al Enazi; Ahad Alawad; Rand Alotaibi; Abdulaziz Alshehri; Omar Alhuthaili; Ramesh Vishwakarma; Khalid Bin Saleh; Thamer Alsulaiman; Rahaf Ali Alqahtani; Sajid Hussain; Saja Almazrou; Khalid Al Sulaiman
Journal:  J Intensive Care Med       Date:  2022-04-21       Impact factor: 2.889

Review 2.  Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary disease.

Authors:  A J White; S Gompertz; R A Stockley
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

3.  Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.

Authors:  Khalid Al Sulaiman; Ohoud Aljuhani; Maram Al Dossari; Asma Alshahrani; Aisha Alharbi; Rahmah Algarni; Majed Al Jeraisy; Shmeylan Al Harbi; Abdulmalik Al Katheri; Fahad Al Eidan; Abdulkareem M Al Bekairy; Nouf Al Qahtani; Mashael Al Muqrin; Ramesh Vishwakarma; Ghassan Al Ghamdi
Journal:  Crit Care       Date:  2021-06-30       Impact factor: 9.097

4.  Markers of exacerbation severity in chronic obstructive pulmonary disease.

Authors:  Luigi G Franciosi; Clive P Page; Bartolome R Celli; Mario Cazzola; Michael J Walker; Meindert Danhof; Klaus F Rabe; Oscar E Della Pasqua
Journal:  Respir Res       Date:  2006-05-10

5.  Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.

Authors:  Khalid Al Sulaiman; Ghazwa B Korayem; Ali F Altebainawi; Shmeylan Al Harbi; Abdulrahman Alissa; Abdullah Alharthi; Raed Kensara; Amjaad Alfahed; Ramesh Vishwakarma; Hussain Al Haji; Naif Almohaimid; Omar Al Zumai; Fahad Alrubayan; Abdulmajid Asiri; Nasser Alkahtani; Abdulaziz Alolayan; Samiah Alsohimi; Nawal Melibari; Alaa Almagthali; Seba Aljahdali; Abeer A Alenazi; Alawi S Alsaeedi; Ghassan Al Ghamdi; Omar Al Faris; Joud Alqahtani; Jalal Al Qahtani; Khalid A Alshammari; Khalil I Alshammari; Ohoud Aljuhani
Journal:  Crit Care       Date:  2022-10-03       Impact factor: 19.334

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.